The Novo Nordisk Investigator Sponsored Studies (ISS) Program will accept submissions within our current scientific focus areas as noted below. This is a competitive process. Incomplete submissions or protocols that are not within the scope of these focus areas/have low relevance to the therapeutic area may be rejected without further review. Submissions will be reviewed by relevant Novo Nordisk teams. Decisions will be made based on scientific merit and strategic fit. Please review the submission requirements. The program requests that investigators specify how they will support enrollment of diverse populations in the study.
At Novo Nordisk, we are driven by curiosity. The topics outlined below are intended to provide a general context and not direction. Proposals may include topics beyond those listed here.
Obesity-related complications
- Women’s health
- Skin and inflammatory disorders
- Musculoskeletal disorders
Adolescent obesity
Obesity-related complications:
- Improvement/resolution of ORCs, incl. cardiometabolic risk factors)
- Female health incl. PCOS and amenorrhoea
- Skin and inflammtory disorders
- Musculoskeletal disorders
- Respiratory disorders incl. asthma and OSA
Adolescent obesity
Well-being and mental health:
- Addictive behaviours and cravings
- Appetite and eating behaviours
- Depression or anxiety, low confidence/self-esteem
- Novel patient-reported outcomes
Clinical experience
- Treatment adherence
- Treatment flexibility
- Switch studies
- Innovative treatment solutions
Well-being and mental health
- Addictive behaviours and cravings
- Appetite and eating behaviours
- Quality of weight loss incl. physical function
- Novel patient-reported reported outcomes
Cardiovascular disease
- Mechanistic studies and imaging
- Application form.
- Investigator Curriculum Vitae (signed and dated within the last year)
- Active medical license (e.g., if requesting study drug)
- Conflict of Interest form